Drug-drug interactions between antithrombotics and direct-acting antivirals in hepatitis C virus (HCV) patients: A brief, updated report

Hepatitis C virus (HCV) is one of the leading causes of chronic liver disease affecting over 71 million people worldwide. An increased incidence of atherothrombotic events [e.g. coronary artery disease (CAD), atrial fibrillation (AF)] has been observed in HCV seropositive patients. On the other hand...

Descripción completa

Detalles Bibliográficos
Autores principales: Canonico, Mario Enrico, Sanna, Giuseppe Damiano, Siciliano, Roberta, Scudiero, Fernando, Esposito, Giovanni, Parodi, Guido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395984/
https://www.ncbi.nlm.nih.gov/pubmed/36016569
http://dx.doi.org/10.3389/fphar.2022.916361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395984/
https://www.ncbi.nlm.nih.gov/pubmed/36016569
http://dx.doi.org/10.3389/fphar.2022.916361

Ejemplares similares